ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of April

April 25, 2014

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002